Reuters is looking for an ambitious U.S. Pharmaceutical Industry Reporter with a track record of scoops and agenda-setting stories. The successful candidate will break news on an industry that has suffered a major political loss in the United States and is bracing for new federal efforts to bring down the cost of prescription medicines. This reporter would shed light on the commercial strategies of leading industry players, with a broad view on how new medicines in development will impact companies, investors, patients and providers. At the same time, the candidate will report on how big pharma companies are turning to deals and new business opportunities after having benefited tremendously from developing vaccines and treatments critical to alleviating the COVID-19 pandemic. The reporter would demonstrate a track record of deep source development and show how they would cultivate a roster of sources among pharmaceutical and biotech executives, government health officials and industry investors. The preferred location for the role is New York.